Sort
46,585 grants matching “heart failure”
Data Science Research
$477,366Santosh Kumar · University Of Memphis · U54 · FY2018 · EB
T-box transcription factor Tbx2 in coronary vascular development and disease
$477,249Chenleng Cai · Indiana University Indianapolis · R01 · FY2019 · HL
Quantifying Left Ventricular Ejection Effectiveness
$477,240University Of Pittsburgh At Pittsburgh · R01 · FY2005 · HL
Stem Cells For Myocardial Repair: A Large Bore Magnet Study
$477,223Jianyi Zhang · University Of Minnesota · R01 · FY2009 · HL
Regulation of Fuel Utilization by Lysine Acetylation in the Failing Heart
$477,181Iain Scott · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL
Characterization and targeting of leukemia stem cell metabolism
$477,177Craig T. Jordan · University Of Colorado Denver · R01 · FY2019 · CA
Angiotensin-Converting Enzyme2 in Vascular Endothelial Function
$477,139Mohan K. Raizada · University Of Florida · R01 · FY2010 · HL
III: Medium: Collaborative Research: Robust Large-Scale Electronic Medical Record Data Mining Framework to Conduct Risk Stratification for Personalized Intervention
$477,098Heng Huang · University Of Texas At Arlington · · FY2013 · CSE
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
$477,093Andrew Serghios Barbas · Duke University · U01 · FY2023 · AI
Admixture Mapping for Hypertension in African Americans
$477,056Adebowale A Adeyemo · Howard University · S06 · FY2007 · GM
Shear-Induced Hemostatic Dysfunction and Bleeding in CF-VAD Patients
$477,023Zhongjun Jon Wu · University Of Maryland Baltimore · R01 · FY2018 · HL
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2024 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2020 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2023 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2022 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2021 · AI
Role of Dendritic Cell-mediated T Cell Activation in Salt-sensitive Hypertension
$477,006Steven D Crowley · Duke University · R01 · FY2019 · HL
Real-time imaging of skeletal muscle innervating sensory neurons that signal pain and fatigue
$476,933Charles Jeffery Woodbury · University Of Utah · R01 · FY2020 · NS
Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St
$476,872Anthony O Caggiano · Acorda Therapeutics, Inc. · U01 · FY2014 · NS
CBPR to Reduce Tobacco Smoking among Residents of a Low-Income Urgan Setting
$476,833Fernando A Wagner · Morgan State University · R24 · FY2011 · MD
Virtual Electrode Polarization Hypothesis of Defibrillation
$476,796Igor R Efimov · Washington University · R01 · FY2009 · HL
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes
$476,753Rodica Pop-Busui · University Of Michigan At Ann Arbor · R01 · FY2011 · HL
Autophagy and Megamitochondria in Cardiac Aging and Heart Failure
$476,738Asa B. Gustafsson · University Of California, San Diego · R01 · FY2021 · HL
Global Health Activities in Developing Countries to Combat Non-Communicable Chron
$476,711Sylvester Kimaiyo · Moi University College Of Health Sciences · N01 · FY2011 · HL
Comparison of exercise responses in four ESRD treatments
$476,686University Of California San Francisco · R01 · FY2003 · NR